Fabrication of a Lipopolysaccharide‐Targeting Peptide‐Based Colloid for Alleviating Carbapenem‐Resistant Enterobacteriaceae ‐Induced Cutaneous Infection
Advanced Healthcare Materials · 2025-06 · 14 (16)
DOI: 10.1002/adhm.202500659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 15.05.2025. Verfasst von Ping Zeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, 999077, China. Hauptthemen laut MEDLINE: Carbapenem-Resistant Enterobacteriaceae, Lipopolysaccharides, Anti-Bacterial Agents, Peptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Carbapenem‐resistant Enterobacteriaceae (CRE) becomes a growing threat to human health. Many clinical isolates have shown strong resistance to commonly used antibacterial agents. Inspired by cationic amphiphiles with tandem‐repeat sequence, two novel peptides termed IW (IWRRIWRRIWRRIWRR‐NH 2 ) and WI (WIRRWIRRWIRRWIRR‐NH 2 ) are designed, synthesized, and investigated in this study. Both exhibited favorable antibacterial activity against “superbugs” at micromole level, surpassing conventional antibiotics, like meropenem and imipenem. Adopting the analytic strategies of molecular dynamics simulation in combination with experimental verification, lipopolysaccharide (LPS) is proposed as a potential target for IW with a calculated dissociation constant of 886 ± 879 nM. Though deadly to infamous bacteria, IW demonstrated negligible toxicity to Galleria mellonella ( GM ) larvae at 500 mg kg −1 . For better administration, IW was formulated with a commercial pharmaceutical excipient poloxamer 407 (P407) to fabricate an antibacterial colloid. This material was verified to effectively reduce the bacterial burden of Escherichia coli ‐infected skin in a mouse model by ≈1.5 log compared with the P407‐treated group. Overall, this work expanded the potential arsenal against carbapenem‐resistant strains by introducing a new engineered molecule delivered using a cheap, concise formulation strategy accordingly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, 999077, China.
- School of Pharmacy, Fudan University, Shanghai, 201203, China.
- Department of Food Science and Nutrition, Faculty of Science, The Hong Kong Polytechnic University, Hong Kong, 999077, China.
- State Key Laboratory of Chemical Biology and Drug Discovery and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, 999077, China.
- Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmacy, The Chinese University of Hong Kong, Hong Kong, 999077, China.
ORCID-Profile: Sharon Shui Yee Leung
Zitieren
APA
Zeng, P., Ding, X., Liu, C., Chen, S., Chan, K. F., & Leung, S. S. Y. (2025). Fabrication of a Lipopolysaccharide‐Targeting Peptide‐Based Colloid for Alleviating Carbapenem‐Resistant Enterobacteriaceae ‐Induced Cutaneous Infection. Advanced Healthcare Materials, 14(16). https://doi.org/10.1002/adhm.202500659
Vancouver
Zeng P, Ding X, Liu C, Chen S, Chan KF, Leung SSY. Fabrication of a Lipopolysaccharide‐Targeting Peptide‐Based Colloid for Alleviating Carbapenem‐Resistant Enterobacteriaceae ‐Induced Cutaneous Infection. Advanced Healthcare Materials. 2025;14(16). doi:10.1002/adhm.202500659
BibTeX
@article{Zeng2025,
author = {Zeng, Ping and Ding, Xinyi and Liu, Chenyu and Chen, Sheng and Chan, Kin-Fai and Leung, Sharon Shui Yee},
title = {Fabrication of a Lipopolysaccharide‐Targeting Peptide‐Based Colloid for Alleviating Carbapenem‐Resistant Enterobacteriaceae ‐Induced Cutaneous Infection},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {16},
doi = {10.1002/adhm.202500659}
}
EUVIMED